Latest News about Biotechnology
Recent news which mentions Biotechnology
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
December 01, 2023
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
November 30, 2023
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
From CNBC.com News
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
November 30, 2023
From CNBC.com News
OPEC says oil industry unjustly vilified ahead of climate talks
November 27, 2023
Tickers
OIL
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
November 27, 2023
From CNBC.com News
Oil and gas industry needs to let go of carbon capture as solution to climate change, IEA says
November 23, 2023
Tickers
OIL
From CNBC.com News
Republican Celeste Maloy wins Utah's 2nd Congressional District
November 21, 2023
From CNBC.com News
U.S. gas prices are falling and could hit the cheapest Thanksgiving day price since 2020
November 20, 2023
From CNBC.com News
U.S. to offer another round of free at-home Covid tests starting Monday
November 20, 2023
From CNBC.com News
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
November 17, 2023
From CNBC.com News
U.S. crude prices fall nearly 4% as inventories rise
November 16, 2023
Tickers
OIL
From CNBC.com News
Solar stocks could rebound in 2024 after a brutal year but interest rates will make or break the recovery
November 15, 2023
From CNBC.com News
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
November 13, 2023
Tickers
MBRX
From Benzinga
Exxon aims to become a top lithium producer for electric vehicles with Arkansas drill operation
November 13, 2023
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
From CNBC.com News
Why Is Neurocrine Biosciences Stock Trading Lower Today?
November 10, 2023
From Benzinga
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
November 08, 2023
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.